Obesity
Not recruitingA study to evaluate the efficacy and safety of MET097 in people with obesity or overweight.
- Disease:Obesity
- Substances:–
Hungary- Participants:18–64 years · 65+ years
- Sponsor:Metsera Inc.
Rare diseases
Investigational molecules
Locations
Back to Hungary115 clinical trials in Zalaegerszeg, Hungary across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
HungaryThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on atherosclerotic cardiovascular disease and heart conditions. Studies evaluate new treatments for heart failure, stroke prevention, and post-heart attack recovery.
Current trials are investigating medications for hypertrophic cardiomyopathy and post-stroke treatment options.
Comprehensive research into breast cancer treatments, particularly focusing on hormone receptor-positive and triple-negative variants. Studies evaluate novel therapeutic approaches.
Multiple trials are exploring new treatment options for various stages of breast cancer.
Research initiatives examining treatments for Type 2 Diabetes and obesity. Studies focus on cardiovascular outcomes and weight management solutions.
Current studies evaluate innovative medications for improved metabolic control.
Tell us about your condition – we search every trial in Europe and connect you with the right site.